tiprankstipranks
Trending News
More News >
Short Report: Bears sell into sharp rally in Hims & Hers
PremiumThe FlyShort Report: Bears sell into sharp rally in Hims & Hers
27d ago
Madrigal Pharmaceuticals: Strong Market Performance and Growth Potential with Rezdiffra Leading the NASH Market
Premium
Ratings
Madrigal Pharmaceuticals: Strong Market Performance and Growth Potential with Rezdiffra Leading the NASH Market
1M ago
Madrigal Pharmaceuticals price target raised to $458 from $441 at UBS
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $458 from $441 at UBS
1M ago
Madrigal Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatingsMadrigal Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
1M ago
Madrigal Pharmaceuticals reports Q1 EPS ($3.32), consensus ($3.79)
Premium
The Fly
Madrigal Pharmaceuticals reports Q1 EPS ($3.32), consensus ($3.79)
1M ago
Madrigal Pharmaceuticals announces six presentations at EASL Congress
Premium
The Fly
Madrigal Pharmaceuticals announces six presentations at EASL Congress
1M ago
Madrigal Pharmaceuticals management to meet with Oppenheimer
PremiumThe FlyMadrigal Pharmaceuticals management to meet with Oppenheimer
3M ago
Madrigal Pharmaceuticals Expands Board with New Appointment
Premium
Company Announcements
Madrigal Pharmaceuticals Expands Board with New Appointment
3M ago
Madrigal Pharmaceuticals appoints Fouse to its board of directors
Premium
The Fly
Madrigal Pharmaceuticals appoints Fouse to its board of directors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100